News
Responses to an interview study demonstrated that patient education on palliative care led to better understanding of its benefits and greater utilization of these services.
Adjuvant cemiplimab could be a new standard of care for patients with cutaneous squamous cell carcinoma at high risk of recurrence, according to Danny Rischin, MD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results